Offerings

What's Going On With AST SpaceMobile Stock Wednesday?

What's Going On With AST SpaceMobile Stock Wednesday?

AST SpaceMobile Stock Gets Dragged Down After Hours: Here's Why

AST SpaceMobile Stock Gets Dragged Down After Hours: Here's Why

Bitfarms Stock Falls As Convertible Notes Swell To $500 Million

Bitfarms Stock Falls As Convertible Notes Swell To $500 Million

AST SpaceMobile Stock Gets Dragged Down After Hours: Here's Why

AST SpaceMobile Stock Gets Dragged Down After Hours: Here's Why

Bitfarms Stock Falls As Convertible Notes Swell To $500 Million

Bitfarms Stock Falls As Convertible Notes Swell To $500 Million

Standard Lithium Stock Slides Nearly 14% After Announcing $120 Million Public Offering

Standard Lithium Stock Slides Nearly 14% After Announcing $120 Million Public Offering

Why Did Dragonfly Energy Shares Jump Over 6% After Hours?

Why Did Dragonfly Energy Shares Jump Over 6% After Hours?

Standard Lithium Stock Slides Nearly 14% After Announcing $120 Million Public Offering

Standard Lithium Stock Slides Nearly 14% After Announcing $120 Million Public Offering

Why Did Dragonfly Energy Shares Jump Over 6% After Hours?

Why Did Dragonfly Energy Shares Jump Over 6% After Hours?

Why American Resources Stock Surged After Hours?

Why American Resources Stock Surged After Hours?

Bitfarms Stock Is Tumbling After Hours: Why Investors Are Selling Shares

Bitfarms Stock Is Tumbling After Hours: Why Investors Are Selling Shares

Offerings Recent News

ASP Isotopes Stock Tumbles After Company Announces Public Offering

ASP Isotopes Stock Tumbles After Company Announces Public Offering

ASP Isotopes Inc (NASDAQ:ASPI) shares are trading lower on Wednesday after the company announced the pricing of an underwritten public offering.

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study

EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding.

ASP Isotopes Stock Is Tumbling After Hours: Here's Why (UPDATED)

ASP Isotopes Stock Is Tumbling After Hours: Here's Why (UPDATED)

ASP Isotopes shares are falling in Tuesday's after-hours session after a major company announcement.

Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug

Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug

Zenas BioPharma secures global rights to orelabrutinib in multiple sclerosis, expands autoimmune pipeline, and raises $120 million in private placement.

Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026

Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026

Karyopharm secures $100 million financing, extends cash runway into 2026, projects $42 million–$44 million Q3 revenue, and advances Phase 3 selinexor trial.

IREN Shares Are Sliding Today: What's Going On?

IREN Shares Are Sliding Today: What's Going On?

IREN Ltd (NASDAQ:IREN) shares are moving lower on Wednesday following a proposed offering of convertible senior notes.

Joby Aviation Raises $514 Million At Discount, Stock Slides On Dilution

Joby Aviation Raises $514 Million At Discount, Stock Slides On Dilution

Joby Aviation Inc. (NYSE: JOBY) priced a $513.9 million offering to support FAA certification and commercial service.

Joby Aviation Stock Is Falling In After-Hours Tuesday: What's Behind The Sell-Off?

Joby Aviation Stock Is Falling In After-Hours Tuesday: What's Behind The Sell-Off?

Joby Aviation shares are tumbling in Tuesday's after-hours session after the company filed for a $500 million offering.

IREN Stock Is Tumbling After The Bell: Here's Why

IREN Stock Is Tumbling After The Bell: Here's Why

IREN shares are falling in Tuesday's after-hours session after the company announced a proposed convertible notes offering.

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2.

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

Biomea Fusion reported favorable safety for icovamenib in a 52-week diabetes study, alongside a $25 million public offering.

Dragonfly Energy Stock Falls After 100% Move

Dragonfly Energy Stock Falls After 100% Move

Dragonfly Energy Holdings Corp (DFLI) shares dip as company prices public offering of 20M common stock at $1.25/share, expected to garner $25M in gross proceeds for corporate purposes.

Pixelworks Raises Fresh Cash For Visual Tech Push, Stock Falls

Pixelworks Raises Fresh Cash For Visual Tech Push, Stock Falls

Pixelworks Inc. (PXLW) announced a $7 million stock sale for product development, with 666,667 shares at $10.50 each.